Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-03-18

Clinical Trial Update: Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement [Phase 2, Phase 3]

View source ↗

Summary

An ongoing multi-center Phase 2/3 trial in Israel is evaluating whether minocycline can prevent imminent paralysis after spinal cord trauma or ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Spinal Tumors, Trauma Patients, Minocycline. | Phase 2, Phase 3 | Status: UNKNOWN